CytoDyn Inc. (OTCQB: CYDY) reported on Wednesday that its current trials for investigational drug leronlimab will be put on partial hold for its HIV program and full hold on its COVID-19 program. While the firm did not disclose the reason behind the pause, it said it is “committed to [US Food and Drug Administration] compliance.” … Continue reading FDA Puts CytoDyn Clinical Trials For HIV, COVID-19 On Hold